Argenx
ARGX
#536
Rank
A$61.13 B
Marketcap
$1,006
Share price
-1.83%
Change (1 day)
67.25%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$6.30

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$6.55. In 2022 the company made an earnings per share (EPS) of -$20.65.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.30-69.48%
2022-$20.65